Herbal Supplements Market Size and Share
Herbal Supplements Market Analysis by Mordor Intelligence
In 2025, the global herbal supplements market size was valued at USD 54.23 billion. Projections indicate it will climb to USD 69.74 billion by 2030, marking a steady growth at a 5.16% CAGR. This surge is fueled by a global pivot towards preventive health, merging age-old plant wisdom with modern nutritional science. Regulatory bodies, bolstered by initiatives like the WHO's Traditional Medicine Strategy 2025-2034, are championing the formal inclusion of botanicals in public health. This support not only aids manufacturers in navigating compliance but also accelerates their product rollouts. Meanwhile, the rise of digital retail channels is reshaping the landscape, providing consumers with education and subscription services. Technological strides in extraction, standardization, and sustainable farming are ensuring the potency and security of supplies. However, challenges loom: climate pressures threaten wild herb populations, and ongoing quality-control concerns highlight the urgency for integrated sourcing and blockchain traceability.
Key Report Takeaways
- By geography, North America led with a 41.56% share of the herbal supplements market share in 2024; Asia-Pacific is projected to record the fastest regional CAGR at 8.7% to 2030.
- By type, single botanicals captured 68.56% of the 2024 revenue, while combination botanicals are forecast to expand at a 9.6% CAGR through 2030.
- By form, capsules and softgels held 58.6% revenue share in 2024; gummies and chews are set to grow at a 7.2% CAGR between 2025-2030.
- By functionality, immune-support products accounted for a 42.13% slice of the herbal supplements market size in 2024, and stress-, sleep-, and cognitive-health lines are moving ahead at an 8.9% CAGR through 2030.
- By distribution channel, pharmacies and drug stores retained a 37.33% share in 2024, whereas online retail sales are advancing at a 9.5% CAGR up to 2030.
Global Herbal Supplements Market Trends and Insights
Driver Impact Analysis
| Drivers | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Preference for natural and clean-label products | +1.3% | Global, with strongest impact in North America & Europe | Long term (≥ 4 years) |
| Growth of e-commerce and digital platforms | +1.0% | Global, led by Asia-Pacific and North America | Medium term (2-4 years) |
| Ageing populations driving preventive health spend | +0.9% | North America, Europe, Japan core markets | Long term (≥ 4 years) |
| Product innovation and personalization | +0.8% | North America & EU innovation hubs, expanding globally | Medium term (2-4 years) |
| Influence of traditional medicine systems | +0.6% | Asia-Pacific core, expanding to Western markets | Long term (≥ 4 years) |
| Technological advancements in cultivation and processing | +0.5% | Global, with early adoption in developed markets | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Preference for natural and clean-label products
Consumer demand for transparency and natural ingredients is significantly transforming product development strategies within the herbal supplements market. This shift extends beyond ingredient sourcing to include sustainable packaging solutions, ethical harvesting practices, and a focus on environmental and social responsibility. For instance, Blackmores achieved B Corp certification in 2024, showcasing its commitment to sustainability and ethical business practices. Regulatory developments are further accelerating the transition to natural products. The EU's Heads of Food Safety Agencies identified 117 substances for potential restriction in food supplements, compelling manufacturers to prioritize botanicals with established safety and efficacy profiles[1]Federal Office of Consumer Protection and Food Safety, "First report of the HoA Working Group "Food Supplements"", www.bvl.bund.de. Third-party certifications have also emerged as a critical factor for market access and consumer trust. Products with USP Verified certification, for example, enjoy an 84% trust rate among supplement users, emphasizing the growing importance of quality assurance and transparency. This increasing preference for natural formulations is driving advancements in extraction technologies, standardization processes, and clean-label solutions. These innovations enable manufacturers to deliver consistent potency, meet regulatory requirements, and align with evolving consumer expectations, positioning the industry for sustained growth.
Growth of e-commerce and digital platforms
The digital transformation of herbal supplement distribution has significantly reshaped the market, driving a notable increase in online sales. E-commerce platforms have enabled direct-to-consumer interactions, eliminating traditional retail markups and offering personalized product recommendations tailored to individual health goals and preferences. This shift gained momentum during the COVID-19 pandemic, as consumers increasingly sought convenient and reliable access to health products. Social media platforms, particularly TikTok, have become critical in influencing consumer behavior, creating substantial product awareness and driving sales conversions. This trend is especially pronounced among younger demographics who favor natural health solutions. Additionally, digital platforms have introduced subscription-based models, which enhance customer retention and streamline predictive inventory management. These advancements address persistent supply chain challenges that have historically affected the industry. The integration of artificial intelligence into e-commerce platforms further enhances the consumer experience by enabling sophisticated product matching and delivering educational content. This empowers consumers to navigate the complex herbal supplement landscape with greater confidence and informed decision-making.
Ageing populations driving preventive health spend
Demographic shifts in developed markets, particularly the aging population, are driving sustained demand for preventive health solutions. Herbal supplements are increasingly positioned as natural alternatives to pharmaceutical interventions, aligning with consumer preferences for holistic wellness. According to the U.S. Census Bureau, the global population aged 65 and older is projected to reach 94.7 million by 2060, significantly influencing healthcare spending on preventive measures[2]United States Census Bureau, "Measuring America's People and Economy", www.census.gov. This demographic transition is accompanied by growing awareness of the gut-brain axis and the critical role of microbiome health in overall well-being. Cognitive health has emerged as a high-growth segment within the preventive health market. Adaptogens, such as ashwagandha, are experiencing robust demand as consumers prioritize natural solutions for stress management and mental wellness. The aging population's preference for natural and scientifically validated products is further supported by rising disposable incomes and improved health literacy, enabling manufacturers to adopt premium pricing strategies for high-quality formulations. Additionally, the increasing pressure to contain healthcare costs is encouraging consumers to explore preventive approaches. Herbal supplements, offering cost-effective alternatives to prescription medications, are becoming a preferred choice for maintaining wellness. This trend underscores the growing importance of preventive health solutions in addressing the needs of an aging population while balancing economic considerations.
Product innovation and personalization
Innovations in delivery formats and personalized nutrition strategies are significantly transforming the herbal supplement market, broadening its appeal to a wider consumer base beyond traditional users. The integration of personalization technologies has enabled the development of highly targeted formulations tailored to individual genetic profiles, lifestyle factors, and specific health goals. This trend aligns with growing consumer demand, as 59% of individuals actively seek scientific validation to ensure the efficacy of supplements. Simultaneously, advancements in extraction and standardization technologies are addressing long-standing concerns about the variability of herbal supplements. These innovations ensure consistent potency and enhance bioavailability, improving product reliability and effectiveness. Emerging trends, such as synbiotic formulations that combine probiotics and prebiotics, are gaining momentum in the market. For instance, products like 360GUT, derived from wild thyme, have demonstrated clinical efficacy in optimizing gut microbiome health, underscoring the potential of this innovation category. Furthermore, the adoption of nanotechnology and advanced delivery systems is revolutionizing the industry by improving absorption rates and reducing dosing requirements. These advancements make herbal supplements more convenient, efficient, and appealing to consumers. Sustainability is also becoming a critical focus area, with innovations in eco-friendly packaging and carbon-neutral manufacturing processes serving as key competitive differentiators.
Restraint Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Quality control and product adulteration | -0.4% | Global, with heightened scrutiny in regulated markets | Short term (≤ 2 years) |
| Competition from conventional pharmaceuticals and other natural products | -0.3% | North America & Europe primarily | Medium term (2-4 years) |
| Supply chain vulnerabilities | -0.3% | Global, with Asia-Pacific sourcing dependencies | Short term (≤ 2 years) |
| Regulatory inconsistencies | -0.2% | EU and emerging markets primarily | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Quality control and product adulteration
Amid rising concerns over product quality and authenticity, the American Herbal Products Association has rolled out Good Agricultural Practices to combat contamination and adulteration. The Botanical Adulterants Prevention Program has flagged prevalent substitution and contamination in widely used ingredients, underscoring the need for advanced authentication technologies, such as blockchain-based tracking systems. Regulatory bodies are ramping up their oversight efforts. Notably, an expert group from the EU has proposed restrictions on substances, including coumarin, curcumin, and hypericum perforatum, citing safety concerns. In a move echoing this heightened regulatory vigilance across Europe, the Netherlands is launching a notification system for food supplements, classifying herbal preparations into distinct risk groups. As supply chain transparency becomes paramount for market access, companies are channeling investments into vertical integration and forging direct sourcing relationships, all in a bid to uphold product integrity and traceability.
Competition from conventional pharmaceuticals and other natural products
Pharmaceutical companies are increasingly encroaching on the herbal supplements market, bolstered by the allure of standardized potency profiles from synthetic alternatives. A case in point: Sanofi's bold USD 1 billion acquisition of Qunol in 2025 underscores the pharmaceutical sector's growing appetite for the healthy aging supplement niche, a move that infuses the segment with robust R&D resources and regulatory know-how. Meanwhile, GLP-1 supplement formulations are carving out a niche as viable substitutes for prescription weight management drugs. Companies like GNC are at the forefront, channeling investments into research aimed at crafting natural counterparts to these pharmaceutical solutions. As consumers gravitate towards integrated nutrition solutions, the landscape shifts: functional foods and beverages laced with botanical ingredients are emerging as formidable contenders to traditional supplement formats. On another front, advancements in synthetic biology and precision fermentation are making it feasible to produce nature-identical compounds en masse, posing a potential challenge to conventional botanical sourcing. Adding another layer of complexity, personalized nutrition firms are harnessing genetic testing and biomarker insights, offering tailored supplement regimens that stand in stark contrast to the traditional one-size-fits-all model.
Segment Analysis
By Form: Capsules Dominate While Gummies Transform Access
Gummies and chews are the fastest-growing segment in the botanical supplements market, projected to achieve a 7.2% CAGR through 2030. These formats are transforming market accessibility by overcoming taste-related barriers that have historically hindered consumer adoption. The development of natural sweetening systems, such as monk fruit-based formulations, is enabling manufacturers to create flavorful gummy products that align with clean-label trends by eliminating artificial additives. This format appeals strongly to younger demographics and consumers who find traditional capsules or tablets inconvenient, thereby significantly expanding the total addressable market for herbal supplements.
Capsules and softgels remain the dominant format in the market, holding a 58.6% share in 2024. Their continued leadership is driven by several advantages, including superior ingredient protection, precise dosing, and a robust manufacturing infrastructure. These formats deliver optimal bioavailability for lipophilic compounds and support higher concentration formulations, which are often impractical in gummy or powder forms. The segment's resilience underscores its ability to preserve complex botanical extracts by protecting them from light, moisture, and oxidation, ensuring long-term product efficacy and consumer trust.
Note: Segment shares of all individual segments available upon report purchase
By Functionality: Immune Support Leads as Cognitive Health Surges
In 2024, immune support holds the largest functionality share at 42.13%, reflecting a sustained consumer focus on preventive health measures, a trend that gained momentum following the COVID-19 pandemic. This segment thrives on robust clinical research validating the efficacy of botanicals such as echinacea, elderberry, and astragalus, which are widely recognized for their safety and effectiveness. Seasonal demand patterns further strengthen the segment, offering consistent and predictable revenue opportunities for manufacturers and retailers. Additionally, the integration of traditional immune-supporting botanicals with probiotics and prebiotics highlights the growing consumer awareness of the gut-immune system connection, driving innovation in product formulations. The segment also benefits from endorsements by healthcare practitioners and its inclusion in workplace wellness programs, which increasingly emphasize preventive health strategies, thereby reinforcing its market dominance.
The "stress, sleep, and cognitive health" segment is emerging as the fastest-growing functionality category, with an impressive CAGR of 8.9% projected through 2030. This growth is fueled by rising consumer awareness of mental wellness and the critical interplay between the gut and brain, often referred to as the gut-brain axis. Ashwagandha has become a standout ingredient in this category, gaining widespread acceptance for its adaptogenic properties. The segment's expansion is further supported by the increasing popularity of adaptogens and nootropics among mainstream consumers, who are actively seeking natural, plant-based alternatives to pharmaceutical solutions for managing stress and enhancing cognitive performance. This shift in consumer preferences underscores the segment's potential for sustained growth in the coming years.
By Distribution Channel: Online Retail Disrupts Traditional Pharmacy Model
Online retail stores are set to grow at a 9.5% CAGR through 2030, fundamentally disrupting traditional supplement distribution models. These platforms foster direct-to-consumer relationships and offer personalized shopping experiences. E-commerce platforms not only facilitate sophisticated product education but also implement recommendation systems, aiding consumers in navigating the complexities of botanical supplements. Subscription models on these platforms bolster customer retention and enhance predictive inventory management. This addresses long-standing supply chain challenges in the industry. Furthermore, social media and influencer marketing play pivotal roles in product discovery and purchase conversion, especially among younger demographics inclined towards natural health solutions.
Pharmacies and drug stores command the largest distribution share at 37.33% in 2024. They leverage consumer trust, professional endorsements, and robust supply chain ties with major manufacturers. These outlets not only lend credibility but also ensure accessibility for consumers, guiding them in supplement selection and potential medication interactions. Their strength is particularly evident in catering to older demographics who favor in-person shopping and value pharmacist consultations. Meanwhile, supermarkets and hypermarkets are broadening their supplement ranges, aiming to capture impulse buys and cater to routine health product needs. Other channels, like specialty health stores and direct sales, cater to niche markets but increasingly feel the heat from online alternatives boasting wider selections and competitive pricing.
Note: Segment shares of all individual segments available upon report purchase
By Type: Single Botanicals Lead Traditional Approach
In 2024, single botanical formulations capture a commanding 68.56% of the market, underscoring a consumer shift towards targeted, scientifically validated ingredients. These ingredients boast established safety records and histories of traditional use. Regulatory frameworks bolster this trend, favoring well-documented single botanicals over intricate blends. Notably, the FDA's New Dietary Ingredient Notification streamlines the approval process for individual botanicals. Turmeric, ashwagandha, and echinacea stand out as popular choices, bolstered by extensive clinical research and widespread consumer recognition. The segment's prowess lies in its promise of consistent dosing and predictable outcomes, effectively addressing the industry's historical quality control challenges. Healthcare practitioners frequently endorse single botanicals, valuing their precision in delivering specific therapeutic effects and their reduced risk of interactions with medications or other supplements.
Combination botanical formulations are on a rapid ascent, projected to grow at a 9.6% CAGR through 2030. This surge is fueled by a growing consumer appetite for synergistic effects and holistic wellness solutions. Advances in formulation science play a pivotal role, allowing stable blends of ingredients once deemed incompatible. Companies like Dabur are seizing this opportunity, evident in their launch of "Siens by Dabur," focusing on Ayurvedic combination formulations. The segment draws strength from traditional medicine systems, especially in Asian markets, where the benefits of botanical synergies have been recognized for centuries. Cutting-edge extraction and standardization technologies empower manufacturers to produce consistent combination products, ensuring they harness the potency of each component while amplifying therapeutic benefits. Furthermore, the rising trend of personalized nutrition is spurring demand for bespoke botanical blends, tailored to individual health needs and genetic nuances.
Geography Analysis
In 2024, North America holds a dominant 41.56% market share, bolstered by established regulatory frameworks, heightened consumer awareness, and a robust healthcare infrastructure championing preventive health. The FDA's Dietary Supplement Health and Education Act in the U.S. offers clear marketing guidelines for botanical supplements, endorsing structure-function claims that bolster consumer education. Canada's Natural and Non-prescription Health Products Directorate further enhances regulatory clarity, facilitating cross-border trade and product innovation. With an aging demographic and soaring healthcare costs, the region witnesses a surge in preventive health measures adoption, positioning herbal supplements as budget-friendly alternatives to pharmaceuticals. Meanwhile, Mexico's burgeoning middle class and heightened health awareness are broadening market prospects, especially for culturally accepted traditional botanicals.
Asia-Pacific stands out as the fastest-growing region, projected to grow at a CAGR of 8.7% through 2030. This growth is fueled by the melding of traditional medicine with contemporary wellness trends and a swiftly expanding middle class. The region's rich indigenous botanical resources, coupled with centuries of documented traditional use, bolster both regulatory approvals and consumer trust. In India, the AYUSH ministry champions the integration of traditional medicine, pushing for quality standardization and global market access for Ayurvedic products. China's policies on Traditional Chinese Medicine are paving the way for herbal formulations that, while rooted in tradition, meet global quality benchmarks. The youthful, health-savvy populace is clamoring for innovative delivery methods and tailored nutrition. Japan, with its aging demographic and deep-rooted supplement culture, presents a lucrative market for premium botanical products backed by clinical research. Meanwhile, Southeast Asian nations like Thailand and Indonesia are witnessing a wellness surge, spurred by economic growth and heightened healthcare investments.
Europe, despite its regulatory hurdles, enjoys steady growth. The EU's Traditional Herbal Medicinal Products Directive paves the way for botanical supplements with a history of traditional use. The continent's commitment to sustainability resonates with the ethos of botanical supplements, amplifying demand for ethically sourced and eco-friendly products. Germany spearheads consumption in Europe, boasting a strong acceptance of natural health products and a well-established retail network. Post-Brexit, the UK's regulatory landscape is ripe with opportunities for innovative botanical formulations, even those facing hurdles in other EU territories. Yet, the region grapples with challenges, notably the EU's impending 2025 ban on botanicals with hydroxyanthracene derivatives, necessitating product tweaks and supply chain realignments[3]Europe Food Safety Authority, "Comprehending the Future Prohibition of Botanicals in the EU Containing Hydroxyanthracene Derivatives in 2025", www.efsa.europa.eu. Meanwhile, South America and the Middle East & Africa emerge as potential hotspots, driven by a rising health consciousness and maturing retail landscapes, albeit with many markets still navigating underdeveloped regulatory terrains.
Competitive Landscape
The herbal supplements market, known for its fragmentation, boasts a multitude of regional and international players, each presenting a diverse product lineup. Prominent names in the arena include Herbalife Nutrition Ltd., Amway Corporation, Harbin Pharmaceutical Group (GNC), Dr. Willmar Schwabe GmbH & Co. KG (Nature's Way), and Kirin Holdings Company, Limited (Blackmores). This fragmentation heightens competition, resulting in price pressures and an imperative for ongoing product innovation. Many small and medium enterprises tap into local ingredients and traditional wisdom, fostering trust among niche consumers. Consequently, the market sees limited consolidation, with no single entity commanding a global dominance.
Companies are carving out competitive edges through technology adoption, channeling investments into blockchain for supply chain transparency, AI for tailored consumer experiences, and cutting-edge extraction methods to uphold product quality. The B Corp movement is emerging as a strategic differentiator, with firms like Blackmores and Gaia Herbs securing certifications to underscore their commitment to environmental and social stewardship.
Opportunities abound in areas like personalized nutrition, eco-friendly packaging, and novel delivery methods such as functional drinks and topical solutions. Noteworthy disruptors are surfacing, including firms utilizing genetic testing for tailored supplement advice and synthetic biology ventures crafting nature-equivalent compounds on a large scale. The landscape is further muddied by consolidation moves, highlighted by Nestlé Health Science's acquisition of brands from The Bountiful Company and a flurry of private equity stakes in niche botanical firms.
Herbal Supplements Industry Leaders
-
Herbalife Nutrition Ltd.
-
Amway Corporation
-
Dr. Willmar Schwabe GmbH & Co. KG (Nature's way)
-
Kirin Holdings Company, Limited. (Blackmores)
-
Harbin Pharmaceutical Group Co., Ltd (GNC)
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- April 2025: Vivazen introduced botanical gummies to expand its functional plant-based supplements portfolio. The product line features three formulations: Berry Bliss for energy and focus, Cider Crush for stress relief, and Citrus Chill for relaxation, with effects reported to begin within 20 minutes.
- February 2025: Organic India has expanded its product line with the launch of its new Regenerative Organic Certified teas and herbal supplements at Expo West. The new product line includes Neem supplements, Tulsi Holy Basil supplements, Ashwagandha supplements, and Tulsi Original Tea.
- February 2025: Blue Toad Botanicals has launched a new supplement called You’ve Got Some NERVE, which is the first product to feature Vanizem, an Aframomum melegueta extract by PLT Health Solutions. According to the company, the extract has been clinically evidenced to support measures of mood and sleep, and is featured alongside other botanicals and vitamins including NeuroAEA (Anandamide and Myristicin), Feverfew, passionflower, skullcap, NeuroAGARIC (muscimol), methylated B-complex, benfotiamine, a proprietary terpene stack, and acetyl-L-carnitine.
- December 2024: Himalaya Wellness has launched a new 28-count bottle of PartySmart, featuring a clinically tested herbal formulation. The product supports liver function during alcohol metabolism and aids in reducing acetaldehyde, a compound produced during alcohol breakdown that can cause morning-after discomfort. The single-capsule dosage, taken during alcohol consumption, aims to improve post-celebration recovery.
Global Herbal Supplements Market Report Scope
| Single Botanical |
| Combination Botanical |
| Tablets |
| Capsules/Softgels |
| Gummies/Chews |
| Powders |
| Others |
| Digestive and Gut Health |
| Stress, Sleep and Cognitive Health |
| Immune Support |
| Others |
| Pharmacies and Drug Stores |
| Supermarkets/Hypermarkets |
| Online Retail Stores |
| Other Distribution Channels |
| North America | United States |
| Canada | |
| Mexico | |
| Rest of North America | |
| Europe | Germany |
| United Kingdom | |
| Italy | |
| France | |
| Spain | |
| Netherlands | |
| Poland | |
| Belgium | |
| Sweden | |
| Rest of Europe | |
| Asia-Pacific | China |
| India | |
| Japan | |
| Australia | |
| Indonesia | |
| South Korea | |
| Thailand | |
| Singapore | |
| Rest of Asia-Pacific | |
| South America | Brazil |
| Argentina | |
| Colombia | |
| Chile | |
| Peru | |
| Rest of South America | |
| Middle East and Africa | South Africa |
| Saudi Arabia | |
| United Arab Emirates | |
| Nigeria | |
| Egypt | |
| Morocco | |
| Turkey | |
| Rest of Middle East and Africa |
| By Type | Single Botanical | |
| Combination Botanical | ||
| By Form | Tablets | |
| Capsules/Softgels | ||
| Gummies/Chews | ||
| Powders | ||
| Others | ||
| By Functionality/Health Benefits | Digestive and Gut Health | |
| Stress, Sleep and Cognitive Health | ||
| Immune Support | ||
| Others | ||
| By Distribution Channel | Pharmacies and Drug Stores | |
| Supermarkets/Hypermarkets | ||
| Online Retail Stores | ||
| Other Distribution Channels | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Rest of North America | ||
| Europe | Germany | |
| United Kingdom | ||
| Italy | ||
| France | ||
| Spain | ||
| Netherlands | ||
| Poland | ||
| Belgium | ||
| Sweden | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| India | ||
| Japan | ||
| Australia | ||
| Indonesia | ||
| South Korea | ||
| Thailand | ||
| Singapore | ||
| Rest of Asia-Pacific | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| Chile | ||
| Peru | ||
| Rest of South America | ||
| Middle East and Africa | South Africa | |
| Saudi Arabia | ||
| United Arab Emirates | ||
| Nigeria | ||
| Egypt | ||
| Morocco | ||
| Turkey | ||
| Rest of Middle East and Africa | ||
Key Questions Answered in the Report
What is the current size of the herbal supplements market?
The herbal supplements market size reached USD 54.23 billion in 2025 and is forecast to climb to USD 69.74 billion by 2030.
Which region is growing fastest for herbal supplements?
Asia-Pacific posts the quickest growth at an expected 8.7% CAGR through 2030, fueled by integration of traditional medicine into modern wellness practices.
Which product type dominates sales?
Single botanical formulations held 68.56% of 2024 revenue due to clear regulatory pathways and strong clinical backing.
How quickly are gummy supplements expanding?
Gummies and chews are advancing at a 7.2% CAGR and already represent 34% of U.S. supplement turnover.
Page last updated on: